ReproEndo Drugs - Sheet1 Flashcards
amiloride
blocks Na channels -> decr MC effects in hyperaldosteronism *weaker effect than spirolactone
spironolactone: action, use and dosage (3 doses for 6 diseases)
antagonist at MC receptors (also androgen and progesterone receptors); 25-50 mg daily as K sparing diuretic for HTN and edematous states (CHF, cirrhosis, nephoris); 400 mg daily in primary hyperaldosteronism; 200 mg daily in PCOS (used off label for anti-androgen effects)
spironolactone side effects (4)
hyperkalemia, volume depletion, men: gynecomastia, impaired libido, impotence; women: mest. irregularities
eplerenone
highly selective (and expensive) MC antagonist (not androgens nor progesterone)
contraindications for spironolactone (3)
renal impairment, hyperkalemia, pregnancy
metyrapone
blocks 11-beta enzyme that converts 11-DOC -> cortisol; doesn’t interfere with aldosterone or androgen production (dx adrenal insufficiency as primary or central by seeing relative ACTH/11-DOC levels)
hydrocortisone dosing
physiological: 20-30 mg/day in the am; stress: 50 mg every 6-8 hrs; acute: 100 mg IV/IM every 6-8 hrs (don’t need MC replacement b/c hydrocortisone works as MC above 100 mg)
dex dosing
physiological: .5 mg daily; stress: 2 mg every 12 hrs; acute: 4 mg IV/IM
ketoconazole
non-specific inhibitor of cortisol synthesis (inhibits at 3 steps)
cabergoline
DA agonist used to tx somatotroph adenoma -> paradoxical effect
octreotide
STT analog used to tx somatotroph or thyrotroph adenoma
pegvisomant
GH anatagonist used to tx somatotroph adenoma -> binds only 1/2 receptor and thus blocks it
metformin: action, MOA
prevents gluconeogenesis (and poss glycogenolysis); phosphorylation (activation) of AMPK; improves fasting glucose (little effect on postprandial); not metabolized, renally excreted unchanged (can accum. if renal insuff); adverse: anorexia, nausea, diarrhea, lactic acidosis; benefits: immed onset (altho need to titrate slowly to avoid GI effects), no hypoglycemia, weight neutral (poss loss) -> first drug of choice; contraindications: prone to acidosis, hypoxic states, renal failure, cardiac ischemia, T1DM; need insulin to work!
Metformin effect
improves fasting glucose (little effect on postprandial)
metformin metabolism
not metabolized, renally excreted
metformin adverse effects (4)
anorexia, nausea, diarrhea, lactic acidosis
metformin benefits (3)
immediate onsent, no hypoglycemia, weight neutral
metformin contraind (5)
prone to acidosis, hypoxic states, renal failure, cardiac ischemia, T1DM (need insulin to work)
TZDs: action, MOA
incr. periph tissue sensitivity to insulin; binds to nuclear PPAR-gamma receptor (incr. GLUT4 transcription)
TZD effect
decreases fasting and post-meal glucose
TZD duration/onset
slow onset of action (fasting gluc begins to decrease within 5-7 days but doesn’t completely decline until 2-3 months)
TZD contraind (3)
liver disease, heart failure, renal insufficiency
TZD adverse effects (3)
weight gain (increased water due to Na reabsorption), hepatocellular injury, increased LDL
TZD benefits (3)
reduces TGs, raises HDL, no hypoglycemia
secretagogues: types (2), differences
sulfonylurea and meglitinides; both bind the beta cell ATP-dep K channel but meglitinide binds more quickly and dissociates more quickly (shorter duration -> 3-4 hrs vs 12-24)
sulfonylurea: action, MOA, duration
secretagogue; binds to sulfonyl receptor in beta cell causing depolarization of ATP-dependent K channels; 12-24 hrs duration
sulfonylurea effect
effect on fasting glucose
sulfonylurea metabolism
excreted via kidney with active metabolites (careful w/ renal problems)
sulfonylurea contraind (3)
T1DM, DKA (need fxning beta cells!), sulfa allergy
sulfonyl adverse effects (3)
hypoglycemia, weight gain, hunger
meglitinides: action, MOA, duration and onset, metab, contraindications (4), adverse effects (2), aka
secretagogue; binds to sulfonyl receptor in beta cell causing depolarization of ATP-dependent K channels; 3-4 hrs duration w/ fast onset (give w/ every meal -> hard for compliance); metab: hepatic (P450) w/ most metabs excreted GI; contraind: T1DM, liver failure, DKA, sulfa allergy; adverse effects: low glucose 2-4 hrs after meal, weight gain; aka glinides
meglitinides duration and onset
3-4 hour duration wtih fast onset (different from sulfonylureas)
meglitinides metabolism
hepatic (P450) with most metabolites secreted via GI
meglitinides contraind (4)
T1DM, DKA (need fxning beta cells!), sulfa allergy, liver failure
meglitinides adverse effects (2)
low glucose 2-4 hours after meal, weight gain
alpha-glucoside inhibitors: MOA
delay carbohydrate absorption (inhibits intestinal enzymes ability to break down sugars) and thus incr GLP-1; effects postprandial glucose only; side effects: flatulence, bloating -> titrate slowly to minimize; contraindications: GI disorders (esp IBD); metab: renally excreted unchanged
alpha-glucosidase inhibitors effects
decreases post-prandial glucose
alpha-glucosidase side effects
flatulence, bloating
alpha-glucosidase contraindications
GI disorders
alpha-glucosidase metabolism
renally excreted unchanged